Neuropace, Inc. (NASDAQ: NPCE) Stock Information | RedChip

Neuropace, Inc. (NASDAQ: NPCE)


$11.5300
-0.4000 ( -3.52% ) 10.8K

NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all its revenue from the sales of RNS System to hospitals facilities (typically Level 4 CECs) that implant RNS System.

Market Data


Open


$11.5300

Previous close


$11.9300

Volume


10.8K

Market cap


$346.84M

Day range


$11.4000 - $12.0790

52 week range


$5.4500 - $18.1500

SEC Filings


Form Type Description Pages Date
4 Insider transactions 2 Jun 11, 2024

Latest News